{{Chembox
| ImageFile = Ersentilide.svg
| ImageSize = 200px
| ImageAlt = 
| IUPACName = ''N''-[4-[2-Hydroxy-3-[2-(4-imidazol-1-ylphenoxy)ethylamino]propoxy]phenyl]methanesulfonamide
| OtherNames = 
|Section1={{Chembox Identifiers
| CASNo = 125228-82-2
| PubChem = 130400
| ChEMBL = 99585
| InChI=1S/C21H26N4O5S/c1-31(27,28)24-17-2-6-21(7-3-17)30-15-19(26)14-22-11-13-29-20-8-4-18(5-9-20)25-12-10-23-16-25/h2-10,12,16,19,22,24,26H,11,13-15H2,1H3
| InChIKey= QZWUQVSQIFFFKY-UHFFFAOYSA-N
| SMILES = CS(=O)(=O)NC1=CC=C(C=C1)OCC(CNCCOC2=CC=C(C=C2)N3C=CN=C3)O
|  ChemSpiderID = 115376}}
|Section2={{Chembox Properties
| C=21 | H=26 | N=4 | O=5 | S=1
| Appearance = 
| Density = 
| MeltingPt = 
| BoilingPt = 
| Solubility = }}
|Section3={{Chembox Hazards
| MainHazards = 
| FlashPt = 
| AutoignitionPt = }}
}}

'''Ersentilide''' is a [[beta adrenergic receptor antagonist]].<ref>{{cite journal|pmid=16787210|year=2006|last1=Lombardi|first1=F|last2=Terranova|first2=P|title=Pharmacological treatment of atrial fibrillation: Mechanisms of action and efficacy of class III drugs|volume=13|issue=14|pages=1635â€“53|journal=Current medicinal chemistry|doi=10.2174/092986706777441940}}</ref>

==References==
{{Reflist}}


{{Adrenergics}}

[[Category:Beta blockers]]
[[Category:Imidazoles]]
[[Category:Sulfonamides]]


{{organic-compound-stub}}
{{pharma-stub}}